Stock Analysis on Net
Stock Analysis on Net

Thermo Fisher Scientific Inc. (NYSE:TMO)

Balance Sheet: Assets
Quarterly Data

Beginner level

The balance sheet provides creditors, investors, and analysts with information on company’s resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company’s assets as well as an indication of cash flows that may come from receivables and inventories.

Assets are resources controlled by the company as a result of past events and from which future economic benefits are expected to flow to the entity.

Thermo Fisher Scientific Inc., consolidated balance sheet: assets (quarterly data)

US$ in millions

Microsoft Excel LibreOffice Calc
Sep 26, 2020 Jun 27, 2020 Mar 28, 2020 Dec 31, 2019 Sep 28, 2019 Jun 29, 2019 Mar 30, 2019 Dec 31, 2018 Sep 29, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jul 1, 2017 Apr 1, 2017 Dec 31, 2016 Oct 1, 2016 Jul 2, 2016 Apr 2, 2016 Dec 31, 2015 Sep 26, 2015 Jun 27, 2015 Mar 28, 2015
Cash and cash equivalents 7,540  5,818  2,981  2,399  1,273  2,288  1,106  2,103  1,098  937  950  1,335  741  611  713  786  1,970  663  827  452  503  768  865 
Accounts receivable, less allowances 5,186  4,478  4,508  4,349  4,384  4,129  4,155  4,136  3,852  3,911  3,990  3,879  3,657  3,258  3,097  3,049  2,895  2,709  2,668  2,545  2,544  2,631  2,538 
Inventories 3,829  3,648  3,454  3,370  3,308  3,209  3,124  3,005  2,982  2,866  2,891  2,971  3,126  2,422  2,327  2,213  2,391  2,086  2,155  1,992  1,987  1,962  1,899 
Contract assets, net 697  686  658  603  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  — 
Deferred tax assets —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  263  284  299 
Other current assets 982  1,145  1,137  1,172  1,549  1,597  1,554  1,381  1,634  1,760  1,757  1,236  1,320  1,161  1,111  973  948  873  889  753  728  591  580 
Current assets 18,234  15,775  12,738  11,893  10,514  11,223  9,939  10,625  9,566  9,474  9,588  9,421  8,844  7,453  7,248  7,021  8,204  6,331  6,539  5,741  6,026  6,237  6,181 
Property, plant and equipment, net 5,180  4,887  4,736  4,749  4,420  4,394  4,192  4,165  3,978  3,952  4,059  4,047  3,932  2,600  2,563  2,578  2,599  2,452  2,483  2,449  2,392  2,407  2,384 
Acquisition-related intangible assets, net 12,870  13,170  13,543  14,014  14,311  14,863  14,489  14,978  15,219  15,680  16,393  16,684  17,030  13,576  13,822  13,969  14,522  12,842  13,238  12,758  13,015  13,384  13,623 
Other assets 1,995  2,061  2,057  2,011  1,860  1,733  1,740  1,117  1,173  1,177  1,178  1,227  1,051  1,040  1,020  1,012  1,105  1,082  1,060  1,113  968  940  937 
Goodwill 25,782  25,700  25,614  25,714  25,624  25,757  25,236  25,347  25,142  25,120  25,362  25,290  25,129  21,846  21,560  21,328  21,580  19,547  19,633  18,828  18,746  18,807  18,733 
Long-term assets 45,827  45,818  45,950  46,488  46,215  46,747  45,657  45,607  45,512  45,929  46,992  47,248  47,141  39,061  38,966  38,887  39,806  35,922  36,414  35,148  35,121  35,538  35,677 
Total assets 64,061  61,593  58,688  58,381  56,729  57,970  55,596  56,232  55,078  55,403  56,580  56,669  55,985  46,514  46,214  45,908  48,011  42,253  42,953  40,889  41,147  41,774  41,857 

Based on: 10-Q (filing date: 2020-10-30), 10-Q (filing date: 2020-07-31), 10-Q (filing date: 2020-05-01), 10-K (filing date: 2020-02-26), 10-Q (filing date: 2019-11-01), 10-Q (filing date: 2019-08-02), 10-Q (filing date: 2019-05-03), 10-K (filing date: 2019-02-27), 10-Q (filing date: 2018-11-02), 10-Q (filing date: 2018-08-03), 10-Q (filing date: 2018-05-04), 10-K (filing date: 2018-02-28), 10-Q (filing date: 2017-11-03), 10-Q (filing date: 2017-08-04), 10-Q (filing date: 2017-05-05), 10-K (filing date: 2017-02-28), 10-Q (filing date: 2016-11-04), 10-Q (filing date: 2016-08-05), 10-Q (filing date: 2016-05-06), 10-K (filing date: 2016-02-25), 10-Q (filing date: 2015-10-30), 10-Q (filing date: 2015-07-31), 10-Q (filing date: 2015-05-01).


Assets: Selected Items

Balance sheet item Description The company
Current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Thermo Fisher Scientific Inc.’s current assets increased from Q1 2020 to Q2 2020 and from Q2 2020 to Q3 2020.
Property, plant and equipment, net Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. Thermo Fisher Scientific Inc.’s property, plant and equipment, net increased from Q1 2020 to Q2 2020 and from Q2 2020 to Q3 2020.
Long-term assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. Thermo Fisher Scientific Inc.’s long-term assets decreased from Q1 2020 to Q2 2020 but then slightly increased from Q2 2020 to Q3 2020.
Total assets Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Thermo Fisher Scientific Inc.’s total assets increased from Q1 2020 to Q2 2020 and from Q2 2020 to Q3 2020.

Current Assets: Selected Items

Balance sheet item Description The company
Cash and cash equivalents Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. Thermo Fisher Scientific Inc.’s cash and cash equivalents increased from Q1 2020 to Q2 2020 and from Q2 2020 to Q3 2020.
Accounts receivable, less allowances Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection. Thermo Fisher Scientific Inc.’s accounts receivable, less allowances decreased from Q1 2020 to Q2 2020 but then increased from Q2 2020 to Q3 2020 exceeding Q1 2020 level.
Inventories Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. Thermo Fisher Scientific Inc.’s inventories increased from Q1 2020 to Q2 2020 and from Q2 2020 to Q3 2020.